Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2006
08/02/2006EP1368413A4 Two-layer imageable element comprising thermally reversible polymers
08/02/2006EP1295514B1 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
08/02/2006EP1274692B1 Quinazoline compounds
08/02/2006EP1076057B1 Febrifugine and isofebrifugine and processes for the preparation of both
08/02/2006EP1072576B1 Fluorinating agent, process for producing the same, and use thereof
08/02/2006EP0986551B1 Sulfonamide derivatives, their production and use
08/02/2006CN1812979A Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
08/02/2006CN1812975A Process of making di-aryl urea compounds
08/02/2006CN1812974A N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors
08/02/2006CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides
08/02/2006CN1812964A Heterocyclic methyl sulfone derivative
08/02/2006CN1812824A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
08/02/2006CN1812717A Triazolopyrimidines
08/02/2006CN1810806A Prepn process and intermediate for voriconazole
08/02/2006CN1810802A 3-substituted-4-pyrimidone derivatives
08/02/2006CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives
08/02/2006CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor
08/02/2006CN1267412C CCR-3 receptor antagonists V
08/01/2006US7084272 formylation and methylation of a 1-(6-substituted pyrimidin-4-yloxy)-2-(2-alkoxy-2-lithiooxyvinyl)benzene
08/01/2006US7084222 Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst
08/01/2006US7084163 Applying to plants
08/01/2006US7084158 Substituted propargylamines
08/01/2006US7084147 Anilinoquinazaolines as protein tyrosine kinase inhibitors
08/01/2006US7084144 Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction
08/01/2006US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
08/01/2006US7083832 Combining one or more chiral nonracemic compounds with one or more liquid crystal compounds which have one or more tail groups that are partially fluorinated or that contains one or more silicon atoms
08/01/2006CA2252958C Fungicide salts
08/01/2006CA2208900C Process for preparing 2-pyrimidinecarboxylates
08/01/2006CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
08/01/2006CA2176720C Novel enzyme inhibitors, their synthesis, and methods for use
08/01/2006CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors
07/2006
07/27/2006WO2006076845A1 Process for producing rosuvastatin calcium, intermediate for the preparation of the same and process for producing the intermediate
07/27/2006WO2005061466A9 Novel phenylalanine derivative
07/27/2006US20060167254 Spiro 2,4-pyrimidinediamine compounds and their uses
07/27/2006US20060167253 substituted diaminopyrimidine compounds having HIV inhibiting properties; reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate (4-cyano, 2-pyrimidine- aniline derivative; reaction with acrylonitril
07/27/2006US20060167251 CCR9 inhibitors and methods of use thereof
07/27/2006US20060167249 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
07/27/2006US20060167105 CCR-3 receptor antagonists
07/27/2006US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
07/27/2006US20060167014 Piperazine compounds and medicinal use thereof
07/27/2006US20060167011 Inhibitors of phosphorylation of platelet derived growth factor receptor
07/27/2006US20060167000 veterinary medicine; neurodegenerative diseases; Alzheimers's Disease
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/27/2006US20060166943 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
07/27/2006US20060166859 Compounds and compositions for delivering active agents
07/27/2006DE4238377B4 Flüssigkristallines Medium Liquid-crystalline medium
07/27/2006CA2593166A1 Mitotic kinesin inhibitors
07/26/2006EP1683789A1 Substituted arylsulfonyl(thio)ureas as herbicides
07/26/2006EP1682536A1 Process for the manufacture of the calcium salt of rosuvastatin (e)-7-'4-(4-fluorophenyl)-6-isopropyl-2-'methyl(methylsulfonyl)amino ! pyrimidin-5-yl!(3r,5s)-3,5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof
07/26/2006EP1682520A1 Amide derivatives
07/26/2006EP1682508A1 Phenyl derivatives as ppar agonists
07/26/2006EP1682507A1 Benzannelated compounds as ppar activators
07/26/2006EP1682494A1 Aralkyl amines as cannabinoid receptor modulators
07/26/2006EP1682150A2 Compositions and methods for inducing cell dedifferentiation
07/26/2006EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof
07/26/2006EP1192950B1 Therapeutic drugs for dermatitis exhibiting a biphasic skin reaction containing chymase inhibitors as the active ingredient
07/26/2006EP0801527B1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
07/26/2006EP0655061B2 Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric
07/26/2006CN1809571A Fungicidal triazolopyrimidines.
07/26/2006CN1809569A Pyrimido compounds
07/26/2006CN1809563A Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
07/26/2006CN1809539A Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2
07/26/2006CN1809360A 4-anilino-quinazoline derivatives as antiproliferative agents
07/26/2006CN1809357A Small molecule Toll-like receptor (TLR) antagonists
07/26/2006CN1807418A Rosuvastatin calcium synthesis method
07/26/2006CN1807417A Novel waterless crystallization-free rosuvastatin calcium
07/26/2006CN1266133C Process for preparing acetyl substituted nitrogen-containing heterocyclic compound
07/26/2006CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/26/2006CN1266098C Substituted dicyclohexylalkyl diphenyl derivative with good low-temperature, mutual solubility, its preparation and application
07/25/2006US7081524 O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
07/25/2006US7081461 Quinazoline compounds and pharmaceutical compositions containing them
07/25/2006US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
07/25/2006US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone
07/25/2006US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device
07/25/2006CA2182105C Chloropyrimide intermediates
07/20/2006WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
07/20/2006WO2006059234A3 Bicyclic amides as kinase inhibitors
07/20/2006US20060161002 Tetrahydrocarbazole derivatives and their pharmaceutical use
07/20/2006US20060160832 Nitrogen-containing aromatic derivatives
07/20/2006US20060160808 New carboxylic acid derivatives, their preparation and their use
07/20/2006US20060160802 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide
07/20/2006US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
07/20/2006US20060159956 Fluorene-based derivative and organic electroluminescence device employing the same
07/20/2006US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
07/20/2006DE4327748B4 Cyclopropyl- und Cyclobutyl-Derivate Cyclopropyl and cyclobutyl derivatives
07/20/2006CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
07/20/2006CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues
07/19/2006EP1681058A2 Pharmacologically active cns compounds
07/19/2006EP1680408A2 Ccr3 receptor antagonists
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1368412A4 Imageable element and composition comprising thermally reversible polymers
07/19/2006EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor
07/19/2006CN1805964A 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
07/19/2006CN1805937A N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine D3 receptor.
07/19/2006CN1805748A 2-aminopyrimidine derivatives as RAF kinase inhibitors
07/19/2006CN1803778A Method for preparing 2,4,6-trichloro pyrimidine
07/19/2006CN1803777A Chemical synthesis method of pyrimidine thioketone
07/19/2006CN1264824C Quinazoline derivatives
07/19/2006CN1264823C Process for preparing retroviral protease inhibitors and its intermediates